aluates Reports

$ 0.0

Automative

Global Hypertension Medications Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-17Z13720

Global Hypertension Medications Market Research Report 2023

BUY CHAPTERS

Global Hypertension Medications Market Research Report 2025

Code: QYRE-Auto-17Z13720

Report

May 2025

Pages:95

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pfizer Inc

Novartis

Astrazeneca plc

Bayer

Sanofi

Boehringer Ingelheim

Merck

Lupin Pharmaceuticals

Huahai Pharmaceutical

Jiangsu Jibeier Pharmaceutical

Chengdu Easton Biopharmaceuticals

CR Double-Crane

Shanghai Shyndec Pharmaceutical

CSPC Pharmaceutical Group

Jiangsu Hengrui Medicine

Tianjin Pharmaceutical Da Ren Tang Group

Qingdao Huanghai Pharmaceutical

Hypertension Medications Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Hypertension Medications Market

The global market for Hypertension Medications was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

High blood pressure is a common condition that affects the body"s arteries. It"s also called hypertension. If you have high blood pressure, the force of the blood pushing against the artery walls is consistently too high. The heart has to work harder to pump blood. There are many different high blood pressure medications (antihypertensives) available, each with pros and cons.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Hypertension Medications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hypertension Medications.

The Hypertension Medications market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hypertension Medications market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Hypertension Medications companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Hypertension Medications Market Report

Report Metric	Details
Report Name	Hypertension Medications Market
CAGR	5%
Segment by Type	Calcium Channel Blockers ACE Inhibitors Angiotensin II Receptor Blockers Beta Blockers Compound Drugs Diuretics Others
Segment by Application	Hospital Clinic Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Novartis, AstraZeneca, Bayer, Sanofi, Boehringer Ingelheim, Merck, Lupin Pharmaceuticals, Huahai Pharmaceutical, Jiangsu Jibeier Pharmaceutical, Tianjin Pharmaceutical Da Ren Tang Group, Chengdu Easton Biopharmaceuticals, Qingdao Huanghai Pharmaceutical, CR Double-Crane, Shanghai Shyndec Pharmaceutical, CSPC Pharmaceutical Group, Jiangsu Hengrui Medicine
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hypertension Medications company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Hypertension Medications Market report?

Ans: The main players in the Hypertension Medications Market are Pfizer, Novartis, AstraZeneca, Bayer, Sanofi, Boehringer Ingelheim, Merck, Lupin Pharmaceuticals, Huahai Pharmaceutical, Jiangsu Jibeier Pharmaceutical, Tianjin Pharmaceutical Da Ren Tang Group, Chengdu Easton Biopharmaceuticals, Qingdao Huanghai Pharmaceutical, CR Double-Crane, Shanghai Shyndec Pharmaceutical, CSPC Pharmaceutical Group, Jiangsu Hengrui Medicine

What are the Application segmentation covered in the Hypertension Medications Market report?

Ans: The Applications covered in the Hypertension Medications Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Hypertension Medications Market report?

Ans: The Types covered in the Hypertension Medications Market report are Calcium Channel Blockers, ACE Inhibitors, Angiotensin II Receptor Blockers, Beta Blockers, Compound Drugs, Diuretics, Others

Recommended Reports

Cardiovascular Drugs

Blood Pressure Markets

Prescription Medicines

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Hypertension Medications Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Calcium Channel Blockers

1.2.3 ACE Inhibitors

1.2.4 Angiotensin II Receptor Blockers

1.2.5 Beta Blockers

1.2.6 Compound Drugs

1.2.7 Diuretics

1.2.8 Others

1.3 Market by Application

1.3.1 Global Hypertension Medications Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Hypertension Medications Market Perspective (2020-2031)

2.2 Global Hypertension Medications Growth Trends by Region

2.2.1 Global Hypertension Medications Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Hypertension Medications Historic Market Size by Region (2020-2025)

2.2.3 Hypertension Medications Forecasted Market Size by Region (2026-2031)

2.3 Hypertension Medications Market Dynamics

2.3.1 Hypertension Medications Industry Trends

2.3.2 Hypertension Medications Market Drivers

2.3.3 Hypertension Medications Market Challenges

2.3.4 Hypertension Medications Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Hypertension Medications Players by Revenue

3.1.1 Global Top Hypertension Medications Players by Revenue (2020-2025)

3.1.2 Global Hypertension Medications Revenue Market Share by Players (2020-2025)

3.2 Global Hypertension Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Hypertension Medications Revenue

3.4 Global Hypertension Medications Market Concentration Ratio

3.4.1 Global Hypertension Medications Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Hypertension Medications Revenue in 2024

3.5 Global Key Players of Hypertension Medications Head office and Area Served

3.6 Global Key Players of Hypertension Medications, Product and Application

3.7 Global Key Players of Hypertension Medications, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Hypertension Medications Breakdown Data by Type

4.1 Global Hypertension Medications Historic Market Size by Type (2020-2025)

4.2 Global Hypertension Medications Forecasted Market Size by Type (2026-2031)

5 Hypertension Medications Breakdown Data by Application

5.1 Global Hypertension Medications Historic Market Size by Application (2020-2025)

5.2 Global Hypertension Medications Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Hypertension Medications Market Size (2020-2031)

6.2 North America Hypertension Medications Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Hypertension Medications Market Size by Country (2020-2025)

6.4 North America Hypertension Medications Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Hypertension Medications Market Size (2020-2031)

7.2 Europe Hypertension Medications Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Hypertension Medications Market Size by Country (2020-2025)

7.4 Europe Hypertension Medications Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Hypertension Medications Market Size (2020-2031)

8.2 Asia-Pacific Hypertension Medications Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Hypertension Medications Market Size by Region (2020-2025)

8.4 Asia-Pacific Hypertension Medications Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Hypertension Medications Market Size (2020-2031)

9.2 Latin America Hypertension Medications Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Hypertension Medications Market Size by Country (2020-2025)

9.4 Latin America Hypertension Medications Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Hypertension Medications Market Size (2020-2031)

10.2 Middle East & Africa Hypertension Medications Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Hypertension Medications Market Size by Country (2020-2025)

10.4 Middle East & Africa Hypertension Medications Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Hypertension Medications Introduction

11.1.4 Pfizer Revenue in Hypertension Medications Business (2020-2025)

11.1.5 Pfizer Recent Development

11.2 Novartis

11.2.1 Novartis Company Details

11.2.2 Novartis Business Overview

11.2.3 Novartis Hypertension Medications Introduction

11.2.4 Novartis Revenue in Hypertension Medications Business (2020-2025)

11.2.5 Novartis Recent Development

11.3 AstraZeneca

11.3.1 AstraZeneca Company Details

11.3.2 AstraZeneca Business Overview

11.3.3 AstraZeneca Hypertension Medications Introduction

11.3.4 AstraZeneca Revenue in Hypertension Medications Business (2020-2025)

11.3.5 AstraZeneca Recent Development

11.4 Bayer

11.4.1 Bayer Company Details

11.4.2 Bayer Business Overview

11.4.3 Bayer Hypertension Medications Introduction

11.4.4 Bayer Revenue in Hypertension Medications Business (2020-2025)

11.4.5 Bayer Recent Development

11.5 Sanofi

11.5.1 Sanofi Company Details

11.5.2 Sanofi Business Overview

11.5.3 Sanofi Hypertension Medications Introduction

11.5.4 Sanofi Revenue in Hypertension Medications Business (2020-2025)

11.5.5 Sanofi Recent Development

11.6 Boehringer Ingelheim

11.6.1 Boehringer Ingelheim Company Details

11.6.2 Boehringer Ingelheim Business Overview

11.6.3 Boehringer Ingelheim Hypertension Medications Introduction

11.6.4 Boehringer Ingelheim Revenue in Hypertension Medications Business (2020-2025)

11.6.5 Boehringer Ingelheim Recent Development

11.7 Merck

11.7.1 Merck Company Details

11.7.2 Merck Business Overview

11.7.3 Merck Hypertension Medications Introduction

11.7.4 Merck Revenue in Hypertension Medications Business (2020-2025)

11.7.5 Merck Recent Development

11.8 Lupin Pharmaceuticals

11.8.1 Lupin Pharmaceuticals Company Details

11.8.2 Lupin Pharmaceuticals Business Overview

11.8.3 Lupin Pharmaceuticals Hypertension Medications Introduction

11.8.4 Lupin Pharmaceuticals Revenue in Hypertension Medications Business (2020-2025)

11.8.5 Lupin Pharmaceuticals Recent Development

11.9 Huahai Pharmaceutical

11.9.1 Huahai Pharmaceutical Company Details

11.9.2 Huahai Pharmaceutical Business Overview

11.9.3 Huahai Pharmaceutical Hypertension Medications Introduction

11.9.4 Huahai Pharmaceutical Revenue in Hypertension Medications Business (2020-2025)

11.9.5 Huahai Pharmaceutical Recent Development

11.10 Jiangsu Jibeier Pharmaceutical

11.10.1 Jiangsu Jibeier Pharmaceutical Company Details

11.10.2 Jiangsu Jibeier Pharmaceutical Business Overview

11.10.3 Jiangsu Jibeier Pharmaceutical Hypertension Medications Introduction

11.10.4 Jiangsu Jibeier Pharmaceutical Revenue in Hypertension Medications Business (2020-2025)

11.10.5 Jiangsu Jibeier Pharmaceutical Recent Development

11.11 Tianjin Pharmaceutical Da Ren Tang Group

11.11.1 Tianjin Pharmaceutical Da Ren Tang Group Company Details

11.11.2 Tianjin Pharmaceutical Da Ren Tang Group Business Overview

11.11.3 Tianjin Pharmaceutical Da Ren Tang Group Hypertension Medications Introduction

11.11.4 Tianjin Pharmaceutical Da Ren Tang Group Revenue in Hypertension Medications Business (2020-2025)

11.11.5 Tianjin Pharmaceutical Da Ren Tang Group Recent Development

11.12 Chengdu Easton Biopharmaceuticals

11.12.1 Chengdu Easton Biopharmaceuticals Company Details

11.12.2 Chengdu Easton Biopharmaceuticals Business Overview

11.12.3 Chengdu Easton Biopharmaceuticals Hypertension Medications Introduction

11.12.4 Chengdu Easton Biopharmaceuticals Revenue in Hypertension Medications Business (2020-2025)

11.12.5 Chengdu Easton Biopharmaceuticals Recent Development

11.13 Qingdao Huanghai Pharmaceutical

11.13.1 Qingdao Huanghai Pharmaceutical Company Details

11.13.2 Qingdao Huanghai Pharmaceutical Business Overview

11.13.3 Qingdao Huanghai Pharmaceutical Hypertension Medications Introduction

11.13.4 Qingdao Huanghai Pharmaceutical Revenue in Hypertension Medications Business (2020-2025)

11.13.5 Qingdao Huanghai Pharmaceutical Recent Development

11.14 CR Double-Crane

11.14.1 CR Double-Crane Company Details

11.14.2 CR Double-Crane Business Overview

11.14.3 CR Double-Crane Hypertension Medications Introduction

11.14.4 CR Double-Crane Revenue in Hypertension Medications Business (2020-2025)

11.14.5 CR Double-Crane Recent Development

11.15 Shanghai Shyndec Pharmaceutical

11.15.1 Shanghai Shyndec Pharmaceutical Company Details

11.15.2 Shanghai Shyndec Pharmaceutical Business Overview

11.15.3 Shanghai Shyndec Pharmaceutical Hypertension Medications Introduction

11.15.4 Shanghai Shyndec Pharmaceutical Revenue in Hypertension Medications Business (2020-2025)

11.15.5 Shanghai Shyndec Pharmaceutical Recent Development

11.16 CSPC Pharmaceutical Group

11.16.1 CSPC Pharmaceutical Group Company Details

11.16.2 CSPC Pharmaceutical Group Business Overview

11.16.3 CSPC Pharmaceutical Group Hypertension Medications Introduction

11.16.4 CSPC Pharmaceutical Group Revenue in Hypertension Medications Business (2020-2025)

11.16.5 CSPC Pharmaceutical Group Recent Development

11.17 Jiangsu Hengrui Medicine

11.17.1 Jiangsu Hengrui Medicine Company Details

11.17.2 Jiangsu Hengrui Medicine Business Overview

11.17.3 Jiangsu Hengrui Medicine Hypertension Medications Introduction

11.17.4 Jiangsu Hengrui Medicine Revenue in Hypertension Medications Business (2020-2025)

11.17.5 Jiangsu Hengrui Medicine Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Pfizer Inc

Novartis

Astrazeneca plc

Bayer

Sanofi

Boehringer Ingelheim

Merck

Lupin Pharmaceuticals

Huahai Pharmaceutical

Jiangsu Jibeier Pharmaceutical

Chengdu Easton Biopharmaceuticals

CR Double-Crane

Shanghai Shyndec Pharmaceutical

CSPC Pharmaceutical Group

Jiangsu Hengrui Medicine

Tianjin Pharmaceutical Da Ren Tang Group

Qingdao Huanghai Pharmaceutical

List of Tables

Table 1. Global Hypertension Medications Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Calcium Channel Blockers

Table 3. Key Players of ACE Inhibitors

Table 4. Key Players of Angiotensin II Receptor Blockers

Table 5. Key Players of Beta Blockers

Table 6. Key Players of Compound Drugs

Table 7. Key Players of Diuretics

Table 8. Key Players of Others

Table 9. Global Hypertension Medications Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 10. Global Hypertension Medications Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 11. Global Hypertension Medications Market Size by Region (2020-2025) & (US$ Million)

Table 12. Global Hypertension Medications Market Share by Region (2020-2025)

Table 13. Global Hypertension Medications Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 14. Global Hypertension Medications Market Share by Region (2026-2031)

Table 15. Hypertension Medications Market Trends

Table 16. Hypertension Medications Market Drivers

Table 17. Hypertension Medications Market Challenges

Table 18. Hypertension Medications Market Restraints

Table 19. Global Hypertension Medications Revenue by Players (2020-2025) & (US$ Million)

Table 20. Global Hypertension Medications Market Share by Players (2020-2025)

Table 21. Global Top Hypertension Medications Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hypertension Medications as of 2024)

Table 22. Ranking of Global Top Hypertension Medications Companies by Revenue (US$ Million) in 2024

Table 23. Global 5 Largest Players Market Share by Hypertension Medications Revenue (CR5 and HHI) & (2020-2025)

Table 24. Global Key Players of Hypertension Medications, Headquarters and Area Served

Table 25. Global Key Players of Hypertension Medications, Product and Application

Table 26. Global Key Players of Hypertension Medications, Date of Enter into This Industry

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Hypertension Medications Market Size by Type (2020-2025) & (US$ Million)

Table 29. Global Hypertension Medications Revenue Market Share by Type (2020-2025)

Table 30. Global Hypertension Medications Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 31. Global Hypertension Medications Revenue Market Share by Type (2026-2031)

Table 32. Global Hypertension Medications Market Size by Application (2020-2025) & (US$ Million)

Table 33. Global Hypertension Medications Revenue Market Share by Application (2020-2025)

Table 34. Global Hypertension Medications Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 35. Global Hypertension Medications Revenue Market Share by Application (2026-2031)

Table 36. North America Hypertension Medications Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. North America Hypertension Medications Market Size by Country (2020-2025) & (US$ Million)

Table 38. North America Hypertension Medications Market Size by Country (2026-2031) & (US$ Million)

Table 39. Europe Hypertension Medications Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 40. Europe Hypertension Medications Market Size by Country (2020-2025) & (US$ Million)

Table 41. Europe Hypertension Medications Market Size by Country (2026-2031) & (US$ Million)

Table 42. Asia-Pacific Hypertension Medications Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 43. Asia-Pacific Hypertension Medications Market Size by Region (2020-2025) & (US$ Million)

Table 44. Asia-Pacific Hypertension Medications Market Size by Region (2026-2031) & (US$ Million)

Table 45. Latin America Hypertension Medications Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Latin America Hypertension Medications Market Size by Country (2020-2025) & (US$ Million)

Table 47. Latin America Hypertension Medications Market Size by Country (2026-2031) & (US$ Million)

Table 48. Middle East & Africa Hypertension Medications Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 49. Middle East & Africa Hypertension Medications Market Size by Country (2020-2025) & (US$ Million)

Table 50. Middle East & Africa Hypertension Medications Market Size by Country (2026-2031) & (US$ Million)

Table 51. Pfizer Company Details

Table 52. Pfizer Business Overview

Table 53. Pfizer Hypertension Medications Product

Table 54. Pfizer Revenue in Hypertension Medications Business (2020-2025) & (US$ Million)

Table 55. Pfizer Recent Development

Table 56. Novartis Company Details

Table 57. Novartis Business Overview

Table 58. Novartis Hypertension Medications Product

Table 59. Novartis Revenue in Hypertension Medications Business (2020-2025) & (US$ Million)

Table 60. Novartis Recent Development

Table 61. AstraZeneca Company Details

Table 62. AstraZeneca Business Overview

Table 63. AstraZeneca Hypertension Medications Product

Table 64. AstraZeneca Revenue in Hypertension Medications Business (2020-2025) & (US$ Million)

Table 65. AstraZeneca Recent Development

Table 66. Bayer Company Details

Table 67. Bayer Business Overview

Table 68. Bayer Hypertension Medications Product

Table 69. Bayer Revenue in Hypertension Medications Business (2020-2025) & (US$ Million)

Table 70. Bayer Recent Development

Table 71. Sanofi Company Details

Table 72. Sanofi Business Overview

Table 73. Sanofi Hypertension Medications Product

Table 74. Sanofi Revenue in Hypertension Medications Business (2020-2025) & (US$ Million)

Table 75. Sanofi Recent Development

Table 76. Boehringer Ingelheim Company Details

Table 77. Boehringer Ingelheim Business Overview

Table 78. Boehringer Ingelheim Hypertension Medications Product

Table 79. Boehringer Ingelheim Revenue in Hypertension Medications Business (2020-2025) & (US$ Million)

Table 80. Boehringer Ingelheim Recent Development

Table 81. Merck Company Details

Table 82. Merck Business Overview

Table 83. Merck Hypertension Medications Product

Table 84. Merck Revenue in Hypertension Medications Business (2020-2025) & (US$ Million)

Table 85. Merck Recent Development

Table 86. Lupin Pharmaceuticals Company Details

Table 87. Lupin Pharmaceuticals Business Overview

Table 88. Lupin Pharmaceuticals Hypertension Medications Product

Table 89. Lupin Pharmaceuticals Revenue in Hypertension Medications Business (2020-2025) & (US$ Million)

Table 90. Lupin Pharmaceuticals Recent Development

Table 91. Huahai Pharmaceutical Company Details

Table 92. Huahai Pharmaceutical Business Overview

Table 93. Huahai Pharmaceutical Hypertension Medications Product

Table 94. Huahai Pharmaceutical Revenue in Hypertension Medications Business (2020-2025) & (US$ Million)

Table 95. Huahai Pharmaceutical Recent Development

Table 96. Jiangsu Jibeier Pharmaceutical Company Details

Table 97. Jiangsu Jibeier Pharmaceutical Business Overview

Table 98. Jiangsu Jibeier Pharmaceutical Hypertension Medications Product

Table 99. Jiangsu Jibeier Pharmaceutical Revenue in Hypertension Medications Business (2020-2025) & (US$ Million)

Table 100. Jiangsu Jibeier Pharmaceutical Recent Development

Table 101. Tianjin Pharmaceutical Da Ren Tang Group Company Details

Table 102. Tianjin Pharmaceutical Da Ren Tang Group Business Overview

Table 103. Tianjin Pharmaceutical Da Ren Tang Group Hypertension Medications Product

Table 104. Tianjin Pharmaceutical Da Ren Tang Group Revenue in Hypertension Medications Business (2020-2025) & (US$ Million)

Table 105. Tianjin Pharmaceutical Da Ren Tang Group Recent Development

Table 106. Chengdu Easton Biopharmaceuticals Company Details

Table 107. Chengdu Easton Biopharmaceuticals Business Overview

Table 108. Chengdu Easton Biopharmaceuticals Hypertension Medications Product

Table 109. Chengdu Easton Biopharmaceuticals Revenue in Hypertension Medications Business (2020-2025) & (US$ Million)

Table 110. Chengdu Easton Biopharmaceuticals Recent Development

Table 111. Qingdao Huanghai Pharmaceutical Company Details

Table 112. Qingdao Huanghai Pharmaceutical Business Overview

Table 113. Qingdao Huanghai Pharmaceutical Hypertension Medications Product

Table 114. Qingdao Huanghai Pharmaceutical Revenue in Hypertension Medications Business (2020-2025) & (US$ Million)

Table 115. Qingdao Huanghai Pharmaceutical Recent Development

Table 116. CR Double-Crane Company Details

Table 117. CR Double-Crane Business Overview

Table 118. CR Double-Crane Hypertension Medications Product

Table 119. CR Double-Crane Revenue in Hypertension Medications Business (2020-2025) & (US$ Million)

Table 120. CR Double-Crane Recent Development

Table 121. Shanghai Shyndec Pharmaceutical Company Details

Table 122. Shanghai Shyndec Pharmaceutical Business Overview

Table 123. Shanghai Shyndec Pharmaceutical Hypertension Medications Product

Table 124. Shanghai Shyndec Pharmaceutical Revenue in Hypertension Medications Business (2020-2025) & (US$ Million)

Table 125. Shanghai Shyndec Pharmaceutical Recent Development

Table 126. CSPC Pharmaceutical Group Company Details

Table 127. CSPC Pharmaceutical Group Business Overview

Table 128. CSPC Pharmaceutical Group Hypertension Medications Product

Table 129. CSPC Pharmaceutical Group Revenue in Hypertension Medications Business (2020-2025) & (US$ Million)

Table 130. CSPC Pharmaceutical Group Recent Development

Table 131. Jiangsu Hengrui Medicine Company Details

Table 132. Jiangsu Hengrui Medicine Business Overview

Table 133. Jiangsu Hengrui Medicine Hypertension Medications Product

Table 134. Jiangsu Hengrui Medicine Revenue in Hypertension Medications Business (2020-2025) & (US$ Million)

Table 135. Jiangsu Hengrui Medicine Recent Development

Table 136. Research Programs/Design for This Report

Table 137. Key Data Information from Secondary Sources

Table 138. Key Data Information from Primary Sources

Table 139. Authors List of This Report

List of Figures

Figure 1. Hypertension Medications Picture

Figure 2. Global Hypertension Medications Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Hypertension Medications Market Share by Type: 2024 VS 2031

Figure 4. Calcium Channel Blockers Features

Figure 5. ACE Inhibitors Features

Figure 6. Angiotensin II Receptor Blockers Features

Figure 7. Beta Blockers Features

Figure 8. Compound Drugs Features

Figure 9. Diuretics Features

Figure 10. Others Features

Figure 11. Global Hypertension Medications Market Size by Application (2020-2031) & (US$ Million)

Figure 12. Global Hypertension Medications Market Share by Application: 2024 VS 2031

Figure 13. Hospital Case Studies

Figure 14. Clinic Case Studies

Figure 15. Others Case Studies

Figure 16. Hypertension Medications Report Years Considered

Figure 17. Global Hypertension Medications Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 18. Global Hypertension Medications Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 19. Global Hypertension Medications Market Share by Region: 2024 VS 2031

Figure 20. Global Hypertension Medications Market Share by Players in 2024

Figure 21. Global Top Hypertension Medications Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hypertension Medications as of 2024)

Figure 22. The Top 10 and 5 Players Market Share by Hypertension Medications Revenue in 2024

Figure 23. North America Hypertension Medications Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. North America Hypertension Medications Market Share by Country (2020-2031)

Figure 25. United States Hypertension Medications Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Canada Hypertension Medications Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Hypertension Medications Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Europe Hypertension Medications Market Share by Country (2020-2031)

Figure 29. Germany Hypertension Medications Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. France Hypertension Medications Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. U.K. Hypertension Medications Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Italy Hypertension Medications Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Russia Hypertension Medications Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Nordic Countries Hypertension Medications Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Hypertension Medications Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Asia-Pacific Hypertension Medications Market Share by Region (2020-2031)

Figure 37. China Hypertension Medications Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Japan Hypertension Medications Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. South Korea Hypertension Medications Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Southeast Asia Hypertension Medications Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. India Hypertension Medications Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Australia Hypertension Medications Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Hypertension Medications Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Latin America Hypertension Medications Market Share by Country (2020-2031)

Figure 45. Mexico Hypertension Medications Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Brazil Hypertension Medications Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Hypertension Medications Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East & Africa Hypertension Medications Market Share by Country (2020-2031)

Figure 49. Turkey Hypertension Medications Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Hypertension Medications Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. UAE Hypertension Medications Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. Pfizer Revenue Growth Rate in Hypertension Medications Business (2020-2025)

Figure 53. Novartis Revenue Growth Rate in Hypertension Medications Business (2020-2025)

Figure 54. AstraZeneca Revenue Growth Rate in Hypertension Medications Business (2020-2025)

Figure 55. Bayer Revenue Growth Rate in Hypertension Medications Business (2020-2025)

Figure 56. Sanofi Revenue Growth Rate in Hypertension Medications Business (2020-2025)

Figure 57. Boehringer Ingelheim Revenue Growth Rate in Hypertension Medications Business (2020-2025)

Figure 58. Merck Revenue Growth Rate in Hypertension Medications Business (2020-2025)

Figure 59. Lupin Pharmaceuticals Revenue Growth Rate in Hypertension Medications Business (2020-2025)

Figure 60. Huahai Pharmaceutical Revenue Growth Rate in Hypertension Medications Business (2020-2025)

Figure 61. Jiangsu Jibeier Pharmaceutical Revenue Growth Rate in Hypertension Medications Business (2020-2025)

Figure 62. Tianjin Pharmaceutical Da Ren Tang Group Revenue Growth Rate in Hypertension Medications Business (2020-2025)

Figure 63. Chengdu Easton Biopharmaceuticals Revenue Growth Rate in Hypertension Medications Business (2020-2025)

Figure 64. Qingdao Huanghai Pharmaceutical Revenue Growth Rate in Hypertension Medications Business (2020-2025)

Figure 65. CR Double-Crane Revenue Growth Rate in Hypertension Medications Business (2020-2025)

Figure 66. Shanghai Shyndec Pharmaceutical Revenue Growth Rate in Hypertension Medications Business (2020-2025)

Figure 67. CSPC Pharmaceutical Group Revenue Growth Rate in Hypertension Medications Business (2020-2025)

Figure 68. Jiangsu Hengrui Medicine Revenue Growth Rate in Hypertension Medications Business (2020-2025)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Essential Hypertension Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Hypertension Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Ocular Hypertension Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Antihypertensive Drugs Market Research Report 2024

Anti intraocular Hypertension Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Blood Pressure Maintenance Supplements Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Blood Pressure Instrument Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Blood Pressure Management Supplements Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Portal Hypertension Market Research Report 2024

Global Hypertensive Heart Disease Drug Market Research Report 2025

Blood Pressure Watch Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Hypertension and Heart Failure Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Blood Pressure Test Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Antihypertensive Agents Market Research Report 2024

Anti Hypertensive Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Medicines for Congestive Heart Failure Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Portal Hypertension Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Blood Pressure Monitor Watch Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Blood Pressure Sensors Market Research Report 2025

RELATED REPORTS

Global Adult Artificial Heart Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32W16534

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Cardioplegia Adapter Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-33A16598

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Inotropic Drug Injection Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-23Y16200

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Retrograde Cardioplegia Cannula Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29Z16493

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions